Article info
PDFSystematic review
The incidence and risk of cutaneous toxicities associated with dabrafenib in melanoma patients: a systematic review and meta-analysis
- Correspondence to Chen Peng, Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan 430060, China; 2282968908{at}qq.com
Citation
The incidence and risk of cutaneous toxicities associated with dabrafenib in melanoma patients: a systematic review and meta-analysis
Publication history
- Received May 2, 2020
- Revised June 20, 2020
- Accepted June 30, 2020
- First published September 3, 2020.
Online issue publication
June 23, 2021
Article Versions
- Previous version (23 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.